文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Lnc-TALC 通过竞争性结合 miR-20b-3p 调控 c-Met 通路促进 O-甲基鸟嘌呤-DNA 甲基转移酶表达。

Lnc-TALC promotes O-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.

机构信息

Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Neuroscience Institute, Heilongjiang Academy of Medical Sciences, 150086, Harbin, China.

Department of Neurosurgery, Tianjin Medical University General Hospital, Lab of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, 300052, Tianjin, China.

出版信息

Nat Commun. 2019 May 3;10(1):2045. doi: 10.1038/s41467-019-10025-2.

DOI:10.1038/s41467-019-10025-2
PMID:31053733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6499807/
Abstract

Long noncoding RNAs (lncRNAs) have emerged as new regulatory molecules implicated in diverse biological processes, including therapeutic resistance. However, the mechanisms underlying lncRNA-mediated temozolomide (TMZ) resistance in glioblastoma (GBM) remain largely unknown. To illustrate the role of lncRNA in TMZ resistance, we induce TMZ-resistant GBM cells, perform a lncRNA microarray of the parental and TMZ-resistant cells, and find an unreported lncRNA in GBM, lnc-TALC (temozolomide-associated lncRNA in glioblastoma recurrence), correlated with TMZ resistance via competitively binding miR-20b-3p to facilitate c-Met expression. A phosphorylated AKT/FOXO3 axis regulated lnc-TALC expression in TMZ-resistant GBM cells. Furthermore, lnc-TALC increased MGMT expression by mediating the acetylation of H3K9, H3K27 and H3K36 in MGMT promoter regions through the c-Met/Stat3/p300 axis. In clinical patients, lnc-TALC is required for TMZ resistance and GBM recurrence. Our results reveal that lnc-TALC in GBM could serve as a therapeutic target to overcome TMZ resistance, enhancing the clinical benefits of TMZ chemotherapy.

摘要

长链非编码 RNA（lncRNA）作为新的调控分子，参与多种生物学过程，包括治疗抵抗。然而，lncRNA 介导胶质母细胞瘤（GBM）替莫唑胺（TMZ）耐药的机制在很大程度上尚不清楚。为了说明 lncRNA 在 TMZ 耐药中的作用，我们诱导 TMZ 耐药的 GBM 细胞，对亲本和 TMZ 耐药细胞进行 lncRNA 微阵列分析，发现了一种在 GBM 中未被报道的 lncRNA，lnc-TALC（胶质瘤复发中与 TMZ 相关的 lncRNA），通过竞争性结合 miR-20b-3p 促进 c-Met 表达，与 TMZ 耐药相关。磷酸化 AKT/FOXO3 轴调节 TMZ 耐药 GBM 细胞中的 lnc-TALC 表达。此外，lnc-TALC 通过 c-Met/Stat3/p300 轴介导 MGMT 启动子区域的 H3K9、H3K27 和 H3K36 的乙酰化，增加 MGMT 的表达。在临床患者中，lnc-TALC 是 TMZ 耐药和 GBM 复发所必需的。我们的结果表明，GBM 中的 lnc-TALC 可以作为克服 TMZ 耐药的治疗靶点，提高 TMZ 化疗的临床获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/77ed6176cb0f/41467_2019_10025_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/c598046bf090/41467_2019_10025_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/28af76f4a629/41467_2019_10025_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/122c925e6fa1/41467_2019_10025_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/4081e64c1369/41467_2019_10025_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/432afce1bcc4/41467_2019_10025_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/9cc6ed0e310c/41467_2019_10025_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/b6b937920271/41467_2019_10025_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/6173bfe26c1b/41467_2019_10025_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/77ed6176cb0f/41467_2019_10025_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/c598046bf090/41467_2019_10025_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/28af76f4a629/41467_2019_10025_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/122c925e6fa1/41467_2019_10025_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/4081e64c1369/41467_2019_10025_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/432afce1bcc4/41467_2019_10025_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/9cc6ed0e310c/41467_2019_10025_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/b6b937920271/41467_2019_10025_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/6173bfe26c1b/41467_2019_10025_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cd/6499807/77ed6176cb0f/41467_2019_10025_Fig9_HTML.jpg

相似文献

[1]
Lnc-TALC promotes O-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.

Nat Commun. 2019-5-3

[2]
IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.

Clin Transl Oncol. 2020-8

[3]
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.

Oncotarget. 2016-11-29

[4]
Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma.

Lab Invest. 2022-2

[5]
AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage.

Life Sci. 2024-11-15

[6]
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.

Mol Cancer. 2020-2-10

[7]
20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.

Cancer Sci. 2018-12-14

[8]
Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment.

J Neurol Sci. 2020-11-15

[9]
Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.

Cancer Lett. 2018-8-10

[10]
MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.

Sci Rep. 2020-6-11

引用本文的文献

[1]
Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance.

Noncoding RNA Res. 2025-8-5

[2]
Lnc-THAP7-AS1 suppresses the ovarian cancer progression by targeting miR-92b-5p/fatty acid 2-hydroxylase signal axis.

Transl Oncol. 2025-8-27

[3]
LncRNA TRPM2-AS promotes cell proliferation, migration, and invasion by regulating the miR-195-5p/COP1 axis in bladder cancer.

Naunyn Schmiedebergs Arch Pharmacol. 2025-6-23

[4]
A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches.

Clin Epigenetics. 2025-6-21

[5]
Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights.

Biomark Res. 2025-5-31

[6]
Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma.

Oncogene. 2025-5-26

[7]
The epigenetic mechanisms involved in the treatment resistance of glioblastoma.

Cancer Drug Resist. 2025-3-13

[8]
The Fetal Environment and the Development of Hypertension-The Epigenetic Modification by Glucocorticoids.

Int J Mol Sci. 2025-1-6

[9]
A novel nuclear RNA HSD52 scaffolding NONO/SFPQ complex modulates DNA damage repair to facilitate temozolomide resistance.

Neuro Oncol. 2025-5-15

[10]
Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential.

Metab Brain Dis. 2024-11-26

本文引用的文献

[1]
lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.

Gene. 2018-10-31

[2]
HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis.

Cell Death Dis. 2018-8-29

[3]
Long noncoding RNA lncARSR promotes epithelial ovarian cancer cell proliferation and invasion by association with HuR and miR-200 family.

Am J Cancer Res. 2018-6-1

[4]
Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway.

Life Sci. 2018-4-18

[5]
Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.

Biochem Biophys Res Commun. 2018-4-30

[6]
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.

Mol Cancer. 2018-2-19

[7]
LncRNA lnc-RI regulates homologous recombination repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a competitive endogenous RNA.

Nucleic Acids Res. 2018-1-25

[8]
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.

Nucleic Acids Res. 2018-2-16

[9]
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Neuro Oncol. 2017-11-6

[10]
Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.

Cell Physiol Biochem. 2017

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索